Previous 10 |
home / stock / vrthf / vrthf news
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the Company's new stra...
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - Veritas Pharma Inc.'s (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) ("Veritas" or the "Company") is pleased to announce that its fully owned subsidiary the Sechelt Organic Marijuana Corp. has completed the sale of its property loc...
The company recently completed clinical trials for its acute pain formulation, CTL-X, which is the most advanced product in the Veritas pipeline Veritas Pharma works in two directions to put together effective cannabis-based treatments for various medical conditions With the help of R&a...
VANCOUVER, British Columbia, July 23, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce that it has reached a settlement with Arbutus Biopharma Corporation (“Arbutus”) with respect...
VANCOUVER, British Columbia, July 10, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has completed the sale of its interest in 3 Carbon Extractions Inc. (“3 Carbon...
VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it has undertaken steps to restructure and rebuild Cannevert Therapeutics Ltd. (“CTL&...
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is pleased to announce the completion of its clinical trial on its lead cannabis...
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce corporate highlights and to communicate the company’s direction for the yea...
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it is proceeding with a consolidation of its issued and outstanding common shares at a rati...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2022) - Indigenous Bloom Hemp Corp. (CSE: IBH) (the "Company" or "Indigenous Bloom" ) announces that it filed its audited financial statements for the year ended May 31, 2022 , on Monday November 28, 2022, including the related manage...
Vancouver, British Columbia--(Newsfile Corp. - October 14, 2022) - Indigenous Bloom Hemp Corp. (CSE: IBH) (the "Company" or "Indigenous Bloom" ) provides a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Tr...
Vancouver, British Columbia--(Newsfile Corp. - August 16, 2022) - Indigenous Bloom Hemp Corp (CSE: IBH) (The "Company" or "IBH"). Further to the Company's news release of April 29 th , 2022 , regarding the Joint Venture with Dykstra Greenhouses, the Company is providing this news release to ac...